Platinum Investment Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-549,899
| Closed | -$3.76M | – | 145 |
|
|
2023
Q1 | $3.76M | Hold |
549,899
| – | – | 0.13% | 66 |
|
|
2022
Q4 | $4.36M | Hold |
549,899
| – | – | 0.17% | 56 |
|
|
2022
Q3 | $5.29M | Sell |
549,899
-48,405
| -8% | -$465K | 0.22% | 49 |
|
|
2022
Q2 | $4.33M | Buy |
598,304
+63,196
| +12% | +$458K | 0.16% | 57 |
|
|
2022
Q1 | $6.91M | Hold |
535,108
| – | – | 0.21% | 55 |
|
|
2021
Q4 | $8.54M | Sell |
535,108
-40,402
| -7% | -$645K | 0.24% | 51 |
|
|
2021
Q3 | $9.25M | Hold |
575,510
| – | – | 0.26% | 47 |
|
|
2021
Q2 | $7.96M | Buy |
575,510
+104,225
| +22% | +$1.44M | 0.18% | 49 |
|
|
2021
Q1 | $6.89M | Buy |
471,285
+329,251
| +232% | +$4.81M | 0.15% | 47 |
|
|
2020
Q4 | $2.47M | Hold |
142,034
| – | – | 0.06% | 83 |
|
|
2020
Q3 | $2.61M | Hold |
142,034
| – | – | 0.06% | 69 |
|
|
2020
Q2 | $2.54M | Sell |
142,034
-34,024
| -19% | -$608K | 0.06% | 75 |
|
|
2020
Q1 | $2.86M | Buy |
176,058
+15,795
| +10% | +$256K | 0.07% | 61 |
|
|
2019
Q4 | $2.89M | Sell |
160,263
-7,974
| -5% | -$144K | 0.06% | 57 |
|
|
2019
Q3 | $3.41M | Hold |
168,237
| – | – | 0.08% | 52 |
|
|
2019
Q2 | $3.72M | Sell |
168,237
-22,261
| -12% | -$492K | 0.09% | 46 |
|
|
2019
Q1 | $2.6M | Sell |
190,498
-24,586
| -11% | -$335K | 0.06% | 52 |
|
|
2018
Q4 | $1.95M | Buy |
215,084
+78,084
| +57% | +$707K | 0.07% | 48 |
|
|
2018
Q3 | $2.26M | Hold |
137,000
| – | – | 0.06% | 50 |
|
|
2018
Q2 | $1.92M | Hold |
137,000
| – | – | 0.05% | 57 |
|
|
2018
Q1 | $1.51M | Buy |
137,000
+27,800
| +25% | +$307K | 0.04% | 59 |
|
|
2017
Q4 | $960K | Hold |
109,200
| – | – | 0.03% | 68 |
|
|
2017
Q3 | $1.46M | Buy |
+109,200
| New | +$1.46M | 0.04% | 59 |
|